{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:08:28Z","timestamp":1756382908478},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1007\/s11912-005-0028-7","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T13:42:31Z","timestamp":1180705351000},"page":"66-73","source":"Crossref","is-referenced-by-count":6,"title":["Leukemia and the nervous system"],"prefix":"10.1007","volume":"7","author":[{"given":"Marc C.","family":"Chamberlain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"28_CR1","doi-asserted-by":"crossref","unstructured":"Xie Y, Davies SM, Xiang Y, et al.: Trends in leukemia incidence and survival in the United States (1973\u20131998), 9:2229\u20132235.","DOI":"10.1002\/cncr.11316"},{"key":"28_CR2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1182\/asheducation-2002.1.162","volume":"1","author":"D Hoelzer","year":"2002","unstructured":"Hoelzer D, Gokbuget N, Ottmann O, et al.: Acute lymphoblastic leukemia. Hematology 2002, 1:162\u2013171.","journal-title":"Hematology"},{"key":"28_CR3","doi-asserted-by":"crossref","unstructured":"Pui C-H, Evans WE: Acute lymphoblastic leukemia. Drug Ther 9:605\u2013615.","DOI":"10.1056\/NEJM199808273390907"},{"key":"28_CR4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0733-8619(02)00030-0","volume":"21","author":"L Recht","year":"2003","unstructured":"Recht L, Mrugala M: Neurologic complications of hematologic neoplasms. Neurol Clin 2003, 21:87\u2013105. A excellent review of neurologic complications in patients with hematologic malignancies.","journal-title":"Neurol Clin"},{"key":"28_CR5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0002-9343(80)90255-7","volume":"68","author":"RJ Meyer","year":"1980","unstructured":"Meyer RJ, Ferreira, PP, Cuttner J, et al.: Central nervous system involvement at presentation in acute granulocytic leukemia: a Prospective Cytocentrifuge Study. Am J Med 1980, 68:691\u2013694.","journal-title":"Am J Med"},{"key":"28_CR6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/1097-0142(19900115)65:2<327::AID-CNCR2820650224>3.0.CO;2-W","volume":"65","author":"T Teshima","year":"1990","unstructured":"Teshima T, Akashi K, Shibuka T, et al.: Central nervous system involvement in adult T-cell leukemia\/lymphoma. Cancer 1990, 65:327\u2013332.","journal-title":"Cancer"},{"key":"28_CR7","first-page":"622","volume":"89","author":"H Kim","year":"2004","unstructured":"Kim H, Lee J-H, Choi S-J, et al.: Analysis of fatal intracranial hemorrhage in 792 acute leukemia patients. Haematologica 2004, 89:622\u2013624.","journal-title":"Haematologica"},{"key":"28_CR8","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2169\/internalmedicine.41.1130","volume":"41","author":"T Kawanami","year":"2002","unstructured":"Kawanami T, Kurita K, Yamakawa M, et al.: Cerebrovascular disease in acute leukemia: a clinicopathological study of 14 patients. Intern Med 2002, 41:1130\u20131134.","journal-title":"Intern Med"},{"key":"28_CR9","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1212\/01.WNL.0000046522.38465.79","volume":"60","author":"P Sostak","year":"2003","unstructured":"Sostak P, Padovan CS, Yousry TA, et al.: Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology 2003, 60:842\u2013848.","journal-title":"Neurology"},{"key":"28_CR10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/WNL.48.2.407","volume":"48","author":"JH Bower","year":"1997","unstructured":"Bower JH, Hammack JE, McDonnell SK, Tefferi A: The neurologic complications of B-cell chronic lymphocytic leukemia. Neurology 1997, 48:407\u2013412.","journal-title":"Neurology"},{"key":"28_CR11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1212\/WNL.46.1.19","volume":"46","author":"SC Cramer","year":"1996","unstructured":"Cramer SC, Glaspy JA, Efird JT, Louis DN: Chronic lymphocytic leukemia and the central nervous system: a clinical and pathological study. Neurology 1996, 46:19\u201325.","journal-title":"Neurology"},{"key":"28_CR12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0733-8619(02)00034-8","volume":"21","author":"SR Plotkin","year":"2003","unstructured":"Plotkin SR, Wen PY. Neurologic complications of cancer therapy. Neurol Clin 2003, 21:279\u2013318. An excellent review of neurologic complications resulting from cancer treatment and, in particular, chemotherapy.","journal-title":"Neurol Clin"},{"key":"28_CR13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0889-8588(05)70203-3","volume":"15","author":"J Cortes","year":"2001","unstructured":"Cortes J: Central nervous system involvement in adult acute lymphocytic leukemia. Hematol Oncol Clin North Am 2001, 15:145\u2013162.","journal-title":"Hematol Oncol Clin North Am"},{"key":"28_CR14","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/1097-0142(197403)33:3<863::AID-CNCR2820330336>3.0.CO;2-1","volume":"33","author":"RW Wolk","year":"1974","unstructured":"Wolk RW, Masse SR, Conklin R, Freireich EJ: The incidence of central nervous system leukemia in adults with acute leukemia. Cancer 1974, 33:863\u2013871.","journal-title":"Cancer"},{"key":"28_CR15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/1097-0142(19810101)47:1<184::AID-CNCR2820470130>3.0.CO;2-M","volume":"47","author":"DJ Stewart","year":"1981","unstructured":"Stewart DJ, Keating MJ, McCredie KB, et al.: Natural history of central nervous system acute leukemia in adults. Cancer 1981, 47:184\u2013196.","journal-title":"Cancer"},{"key":"28_CR16","first-page":"295","volume":"17","author":"C-Y Chen","year":"1996","unstructured":"Chen C-Y, Zimmerman RA, Faro S, et al.: Childhood leukemia: central nervous system abnormalities during and after treatment. AJNR Am J Neuroradiol 1996, 17:295\u2013310.","journal-title":"AJNR Am J Neuroradiol"},{"key":"28_CR17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/cncr.10265","volume":"94","author":"UR Surapaneni","year":"2002","unstructured":"Surapaneni UR, Cortes JE, Thomas D, et al.: Central nervous system relapse in adults with acute lymphoblastic leukemia. Cancer 2002, 94:773\u2013780. The best summary of outcome in adult patients with leukemic meningitis treated at a single institution.","journal-title":"Cancer"},{"key":"28_CR18","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/1097-0142(19870215)59:4<798::AID-CNCR2820590423>3.0.CO;2-B","volume":"59","author":"J Cash","year":"1987","unstructured":"Cash J, Fehir KM, Pollack MS: Meningeal involvement in early stage chronic lymphocytic leukemia. Cancer 1987, 59:798\u2013800.","journal-title":"Cancer"},{"key":"28_CR19","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/1097-0142(19851015)56:8<2078::AID-CNCR2820560832>3.0.CO;2-0","volume":"56","author":"AW Dekker","year":"1985","unstructured":"Dekker AW, Elderson A, Punt K, Sixma JJ: Meningeal involvement in patients with acute nonlymphocytic leukemia. Cancer 1985, 56:2078\u20132082.","journal-title":"Cancer"},{"key":"28_CR20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02341153","volume":"9","author":"JG Kaplan","year":"1990","unstructured":"Kaplan JG, DeSouza TG, Farkash A, et al.: Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol 1990, 9:225\u2013229.","journal-title":"J Neurooncol"},{"key":"28_CR21","first-page":"282","volume-title":"Cancer in the Nervous System","author":"M Chamberlain","year":"1996","unstructured":"Chamberlain M: Leptomeningeal metastases. In Cancer in the Nervous System. Edited by Levin V. New York: Churchill Livingstone; 1996:282\u2013290."},{"issue":"2","key":"28_CR22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/ctrv.1999.0119","volume":"25","author":"SA Grossman","year":"1999","unstructured":"Grossman SA, Krabak MJ: Leptomeningeal carcinomatosis. Cancer Treat Rev 1999; 25, 2:103\u2013119.","journal-title":"Cancer Treat Rev"},{"key":"28_CR23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1005976926058","volume":"37","author":"MC Chamberlain","year":"1998","unstructured":"Chamberlain MC: Leptomeningeal metastases: a review of evaluation and treatment. J Neurooncol 1998, 37:271\u2013284.","journal-title":"J Neurooncol"},{"key":"28_CR24","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1182\/blood.V72.5.1784.1784","volume":"72","author":"HM Kantarjian","year":"1988","unstructured":"Kantarjian HM, Walters RS, Smith TL, et al.: Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia. Blood 1988, 72:1784\u20131789.","journal-title":"Blood"},{"key":"28_CR25","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0002-9343(92)90191-D","volume":"93","author":"HM Kantarjian","year":"1992","unstructured":"Kantarjian HM, Smith T, Estey E, et al.: Prognostic significance of elevated serum beta 2-microglobulin levels in acute lymphocytic leukemia. Am J Med 1992, 93:599\u2013604.","journal-title":"Am J Med"},{"key":"28_CR26","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0145-2126(01)00188-6","volume":"26","author":"F Ravandi","year":"2002","unstructured":"Ravandi F, Cortes J, Estrov Z, et al.: CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia. Leuk Res 2002, 26:643\u2013649.","journal-title":"Leuk Res"},{"key":"28_CR27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1200\/JCO.2000.18.3.547","volume":"18","author":"HM Kantarijian","year":"2000","unstructured":"Kantarijian HM, O\u2019Brien S, Smith TL, et al.: Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol 2000, 18:547\u2013561.","journal-title":"J Clin Oncol"},{"key":"28_CR28","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1056\/NEJM198009253031302","volume":"303","author":"GM Mavlight","year":"1980","unstructured":"Mavlight GM, Stuckey SE, Cabanillas FF, et al.: Diagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determination. N Engl J Med 1980, 303:718\u2013722.","journal-title":"N Engl J Med"},{"key":"28_CR29","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1182\/blood.V87.5.1985.1985","volume":"87","author":"MJ Kersten","year":"1996","unstructured":"Kersten MJ, Evers LM, Dellemijn PL, et al.: Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies. Blood 1996, 87:1985\u20131999.","journal-title":"Blood"},{"key":"28_CR30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1200\/JCO.2003.04.096","volume":"21","author":"B Burger","year":"2003","unstructured":"Burger B, Zimmermann M, Mann G, et al.: Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol 2003, 21:184\u2013188.","journal-title":"J Clin Oncol"},{"key":"28_CR31","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","volume":"49","author":"W Wasserstrom","year":"1982","unstructured":"Wasserstrom W, Glass J, Posner J: Diagnosis and treatment of leptomeningeal metastases from solid tumors experience with 90 patients. Cancer 1982, 49:759\u2013772.","journal-title":"Cancer"},{"key":"28_CR32","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1212\/WNL.53.2.382","volume":"53","author":"RJ Oostenbrugge Van","year":"1999","unstructured":"Van Oostenbrugge RJ, Twijnstra A: Presenting features and value of diagnostic procedures in leptomeningeal metastases. Neurology 1999, 53:382\u2013385.","journal-title":"Neurology"},{"key":"28_CR33","first-page":"239","volume":"11","author":"WR Wasserstrom","year":"1981","unstructured":"Wasserstrom WR, Schwartz MK, Fleisher M, et al.: Cerebrospinal fluid biochemical markers in central nervous system tumors: a review. Ann Clin Lab Sci 1981, 11:239\u2013251.","journal-title":"Ann Clin Lab Sci"},{"key":"28_CR34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0009-8981(86)90009-4","volume":"161","author":"AP Zanten Van","year":"1986","unstructured":"Van Zanten AP, Twijnstra A, Hart AA, et al.: Cerebrospinal fluid lactate dehydrogenase activities in patients with central nervous system metastases. Clin Chim Acta 1986, 161:259\u2013268.","journal-title":"Clin Chim Acta"},{"key":"28_CR35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0025-6196(12)61391-3","volume":"61","author":"GG Klee","year":"1986","unstructured":"Klee GG, Tallman RD, Goellner JR, et al.: Elevation of carcinoembryonic antigen in cerebrospinal fluid among patients with meningeal carcinomatosis. Mayo Clin Proc 1986, 61:9\u201313.","journal-title":"Mayo Clin Proc"},{"key":"28_CR36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/jnnp.50.3.313","volume":"50","author":"A Twijnstra","year":"1987","unstructured":"Twijnstra A, van Zanten AP, Hart AA, et al.: Serial lumbar and ventricle cerebrospinal fluid lactate dehydrogenase activities in patients with leptomeningeal metastases from solid and haematological tumours. J Neurol Neurosurg Psychiatry 1987, 50:313\u2013320.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"28_CR37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF00149379","volume":"7","author":"A Twijnstra","year":"1989","unstructured":"Twijnstra A, Ongerboerd, V, van Zanten AP, et al.: Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors. J Neurooncol 1989, 7:57\u201363.","journal-title":"J Neurooncol"},{"key":"28_CR38","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1212\/WNL.50.4.1173","volume":"50","author":"MC Chamberlain","year":"1998","unstructured":"Chamberlain MC: Cytologically negative carcinomatous meningitis: usefulness of CSF biochemical markers. Neurology 1998, 50:1173\u20131175.","journal-title":"Neurology"},{"key":"28_CR39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF02228893","volume":"3","author":"JA Garson","year":"1985","unstructured":"Garson JA, Coakham HB, Kemshead JT, et al.: The role of monoclonal antibodies in brain tumour diagnosis and cerebrospinal fluid (CSF) cytology. J Neurooncol 1985, 3:165\u2013171.","journal-title":"J Neurooncol"},{"key":"28_CR40","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/jnnp.51.1.142","volume":"51","author":"W Boogerd","year":"1988","unstructured":"Boogerd W, Vroom TM, van Heerde P, et al.: CSF cytology versus immunocytochemistry in meningeal carcinomatosis. J Neurol Neurosurg Psychiatry 1988, 51:142\u2013145.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"28_CR41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1023\/A:1005926624303","volume":"38","author":"RJ Oostenbrugge Van","year":"1998","unstructured":"Van Oostenbrugge RJ, Hopman AH, Ramaekers FC, et al.: In situ hybridization: a possible diagnostic aid in leptomeningeal metastasis. J Neurooncol 1998, 38:127\u2013133.","journal-title":"J Neurooncol"},{"key":"28_CR42","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/ajcp\/88.5.570","volume":"88","author":"ES Cibas","year":"1987","unstructured":"Cibas ES, Malkin MG, Posner JB, et al.: Detection of DNA abnormalities by flow cytometry in cells from cerebrospinal fluid. Am J Clin Pathol 1987, 88:570\u2013577.","journal-title":"Am J Clin Pathol"},{"key":"28_CR43","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/BF00228576","volume":"86","author":"S Biesterfeld","year":"1993","unstructured":"Biesterfeld S, Bernhard B, Bamborschke S, et al.: DNA single cell cytometry in lymphocytic pleocytosis of the cerebrospinal fluid. Acta Neuropathol (Berl) 1993, 86:428\u2013432.","journal-title":"Acta Neuropathol (Berl)"},{"key":"28_CR44","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1212\/WNL.51.3.906","volume":"51","author":"RJ Oostenbrugge Van","year":"1998","unstructured":"Van Oostenbrugge RJ, Hopman AH, Arends JW et al.: The value of interphase cytogenetics in cytology for the diagnosis of leptomeningeal metastases. Neurology 1998, 51:906\u2013908.","journal-title":"Neurology"},{"key":"28_CR45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/WNL.40.3_Part_1.435","volume":"40","author":"M Chamberlain","year":"1990","unstructured":"Chamberlain M, Sandy A, Press G: Leptomeningeal metastasis: a comparison of gadolinium-enhanced MR and contrastenhanced CT of the brain. Neurology 1990, 40:435\u2013438.","journal-title":"Neurology"},{"key":"28_CR46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1005783507544","volume":"36","author":"JM Gomori","year":"1998","unstructured":"Gomori JM, Heching N, Siegal T: Leptomeningeal metastases: evaluation by gadolinium enhanced spinal magnetic resonance imaging. J Neurooncol 1998, 36:55\u201360.","journal-title":"J Neurooncol"},{"key":"28_CR47","first-page":"965","volume":"10","author":"G Sze","year":"1989","unstructured":"Sze G, Soletsky S, Bronen R, et al.: MR imaging of the cranial meninges with emphasis on contrast enhancements and meningeal carcinomatosis. AJNR Am J Neuroradiol 1989, 10:965\u2013975.","journal-title":"AJNR Am J Neuroradiol"},{"key":"28_CR48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF01059954","volume":"23","author":"MC Chamberlain","year":"1995","unstructured":"Chamberlain MC: Comparative spine imaging in leptomeningeal metastases. Neuro-Oncol 1995, 23:233\u2013238.","journal-title":"Neuro-Oncol"},{"key":"28_CR49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.41.1.46","volume":"41","author":"E Kramer","year":"1991","unstructured":"Kramer E, Rafto S, Packer R, et al.: Comparison of myelography with CT follow-up versus gadolinium MRI for subarachnoid metastatic disease in children. Neurology 1991, 41:46\u201350.","journal-title":"Neurology"},{"key":"28_CR50","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1212\/WNL.41.11.1765","volume":"41","author":"M Chamberlain","year":"1991","unstructured":"Chamberlain M, Corey-Bloom J: Leptomeningeal metastases Indium-DTPA CSF flow studies. Neurology 1991, 41:1765\u20131769.","journal-title":"Neurology"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-005-0028-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-005-0028-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-005-0028-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T16:47:28Z","timestamp":1587574048000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-005-0028-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["28"],"URL":"https:\/\/doi.org\/10.1007\/s11912-005-0028-7","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}